Increased α-Defensins as a Blood Marker for Schizophrenia Susceptibility

Harrison, 1999, The neuropathology of schizophrenia. A critical review of the data and their interpretation, Brain, 122, 593, 10.1093/brain/122.4.593 Heinrichs, 1988, Significance and meaning of neurological signs in schizophrenia, Am. J. Psychiatry, 145, 11, 10.1176/ajp.145.1.11 Snitz, 2005, Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment, Am. J. Psychiatry, 162, 2322, 10.1176/appi.ajp.162.12.2322 Gottesman, 1989, Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins, Arch. Gen. Psychiatry, 46, 867, 10.1001/archpsyc.1989.01810100009002 Harrison, 2003, Genes for schizophrenia? Recent findings and their pathophysiological implications, Lancet, 361, 417, 10.1016/S0140-6736(03)12379-3 Leonard, 2002, Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia, Arch. Gen. Psychiatry, 59, 1085, 10.1001/archpsyc.59.12.1085 Straub, 2002, Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia, Am. J. Hum. Genet., 71, 337, 10.1086/341750 Muglia, 2003, Association between the BDNF gene and schizophrenia, Mol. Psychiatry, 8, 146, 10.1038/sj.mp.4001221 Mimmack, 2002, Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22, Proc. Natl. Acad. Sci. U. S. A., 99, 4680, 10.1073/pnas.032069099 Prabakaran, 2004, Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress, Mol. Psychiatry, 9, 684, 10.1038/sj.mp.4001511 Huang, 2006, Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis, PLoS Med., 3, e428, 10.1371/journal.pmed.0030428 Holmes, 2006, Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia, PLoS Med., 3, e327, 10.1371/journal.pmed.0030327 Tsang, 2006, Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients, J. Proteome Res., 5, 756, 10.1021/pr0503782 Prabakaran, 2007, 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia, J. Proteome Res., 6, 141, 10.1021/pr060308a Theodoropoulou, 2001, Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients, Schizophr. Res., 47, 13, 10.1016/S0920-9964(00)00007-4 Cazzullo, 1998, Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients, Schizophr. Res., 31, 49, 10.1016/S0920-9964(97)00153-9 Ferrante, 1998, Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis, J. Immunol., 160, 1514, 10.4049/jimmunol.160.3.1514 Riedel, 2007, Decreased T cellular immune response in schizophrenic patients, J. Psychiatr. Res., 41, 3, 10.1016/j.jpsychires.2005.11.007 Craddock, 2007, Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms, PLoS ONE, 2, e692, 10.1371/journal.pone.0000692 Lehrer, 1993, Defensins: antimicrobial and cytotoxic peptides of mammalian cells, Annu. Rev. Immunol., 11, 105, 10.1146/annurev.iy.11.040193.000541 Selsted, 2005, Mammalian defensins in the antimicrobial immune response, Nat. Immunol., 6, 551, 10.1038/ni1206 Zeya, 1966, Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities, J. Bacteriol., 91, 750, 10.1128/jb.91.2.750-754.1966 Zhang, 2002, Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor, Science, 298, 995, 10.1126/science.1076185 Chalifour, 2004, Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production, Blood, 104, 1778, 10.1182/blood-2003-08-2820 Agerberth, 2000, The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations, Blood, 96, 3086, 10.1182/blood.V96.9.3086 Singh, 1988, Structure of a novel human granulocyte peptide with anti-ACTH activity, Biochem. Biophys. Res. Commun., 155, 524, 10.1016/S0006-291X(88)81118-5 Territo, 1989, Monocyte-chemotactic activity of defensins from human neutrophils, J. Clin. Investig., 84, 2017, 10.1172/JCI114394 Panyutich, 1991, Activated α2-macroglobulin is a principal defensin-binding protein, Am. J. Respir. Cell Mol. Biol., 5, 101, 10.1165/ajrcmb/5.2.101 Enghild, 1989, A conserved region in α-macroglobulins participates in binding to the mammalian α-macroglobulin receptor, Biochemistry, 28, 1406, 10.1021/bi00429a069 Valore, 1992, Posttranslational processing of defensins in immature human myeloid cells, Blood, 79, 1538, 10.1182/blood.V79.6.1538.1538 Yang, 2006, Altered levels of acute phase proteins in the plasma of patients with schizophrenia, Anal. Chem., 78, 3571, 10.1021/ac051916x Morera, 2007, Acute phase proteins as biological markers of negative psychopathology in paranoid schizophrenia, Actas Esp. Psiquiatr., 35, 249 Hazrati, 2006, Human α- and β-defensins block multiple steps in herpes simplex virus infection, J. Immunol., 177, 8658, 10.4049/jimmunol.177.12.8658